Becton Dickinson Announces Departure of Chief Scientific Officer

Becton Dickinson & Co. reported the departure of its chief scientific officer in a Form 8-K filed with the SEC on May 7, 2026.

The filing, which includes Item 5.02 on the departure of directors or principal officers, identifies the named executive but does not specify a named individual in the structured summary. Item 7.01 covers Regulation FD disclosure while Item 9.01 addresses financial statements and exhibits. The company listed no cause for the departure in the reported items.

The departure removes the chief scientific officer from the principal-officer roster that Becton Dickinson maintains for regulatory and operational reporting. Prior to the filing the role sat within the company's executive leadership; the new state leaves the position vacant until the board elects a replacement or reassigns duties.

The change takes effect on the date stated in the filing, which the document ties directly to the May 7, 2026 submission.

Downstream the company must update its proxy statements and officer listings in the next Form 10-K or 10-Q to reflect the vacancy. Any severance, equity acceleration or consulting arrangements tied to the departure contractually require disclosure in a subsequent 8-K within four business days under Item 5.02(b) if material.

The board's compensation committee will next determine whether to initiate a search process or redistribute scientific oversight, actions that also affect the company's reporting on research and development leadership to investors and regulators.

This marks the latest executive-level change reported by Becton Dickinson via Item 5.02. The company has used the same 8-K items in prior years to document officer transitions that later required updated biographies in its annual proxy filing.